{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:19:44Z","timestamp":1784636384796,"version":"3.55.0"},"reference-count":13,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In Argentina, with the aim of moving to a safe supportive and inclusive National Blood System, in September 2015 the Ministry of Health stipulated that eligibility criteria for blood donation should only take into account the so\u2010called 'risk practices', focusing on a 'gender\u2010neutral' policy. The aim of this study is to demonstrate the impact of such regulation on the prevalence of STI in the population of blood donors in Argentina, through the analysis of the scientific evidence obtained from 174\u00a0074 donors from a large central region of the country, focused on a regional Blood Bank for a 6\u2010year period (pre\u2010 and post\u2010entry into force of the regulations).<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>To analyse the evolution of prevalence rates of STI, two periods of 3\u00a0years each were evaluated: The first period (P1) lasted from 16 September 2012 to 15 September 2015 (prior to the entry into force of the law) and the second one (P2) from 16 September 2015 to 15 September 2018 (after the entry into force of the law).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 82\u00a0838 subjects were enrolled in P1 and 91\u00a0236 in P2. The results show a significantly lower prevalence of HCV (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7029), HBV (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7028) and syphilis (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7001) in P2, while no difference was observed for HIV infection (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b760).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study evidenced that the implementation of a 'gender\u2010neutral' policy based on individual risk\u2010assessment deferral criteria maintained the safety of blood supply and decreased the prevalence of STI among blood donors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vox.12933","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T12:09:32Z","timestamp":1588594172000},"page":"548-554","source":"Crossref","is-referenced-by-count":14,"title":["Gender\u2010neutral donor deferral policies: experience in Argentina implementing individual risk\u2010assessment policies"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-2833","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Blanco","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n Banco Central de Sangre C\u00f3rdoba Argentina"},{"name":"Instituto de Virolog\u00eda Dr. J.M. Vanella Facultad de Ciencias M\u00e9dicas Universidad Nacional de C\u00f3rdoba C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Horacio","family":"Carrizo","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Banco Central de Sangre C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando Walter","family":"Moyano","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Banco Central de Sangre C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Mangeaud","sequence":"additional","affiliation":[{"name":"C\u00e1tedra de Bioestad\u00edstica. Facultad de Ciencias Exactas F\u00edsicas y Naturales Universidad Nacional de C\u00f3rdoba C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Ver\u00f3nica","family":"Gallego","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Banco Central de Sangre C\u00f3rdoba Argentina"},{"name":"Instituto de Virolog\u00eda Dr. J.M. Vanella Facultad de Ciencias M\u00e9dicas Universidad Nacional de C\u00f3rdoba C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Food and Drug Administration:Blood product advisory committee meeting. Topic III: Blood donation policies regarding men who have sex with men (MSM) 2019.Silver Spring MD:FDA. Available onhttps:\/\/www.fda.gov\/media\/120953\/download[Last accessed 20 August 2019]"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12623"},{"key":"e_1_2_6_4_1","first-page":"7","article-title":"Blood donor deferral policies across Europe and characteristics of men who have sex with men screened for human immunodeficiency virus in blood establishments: data from the European Men\u2010who\u2010have\u2010sex\u2010with\u2010men Internet survey (EMIS)","volume":"16","author":"Schink SB","year":"2018","journal-title":"Blood Transf"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02793.x"},{"key":"e_1_2_6_6_1","first-page":"441","article-title":"Changing blood donor screening criteria from permanent deferral for men who have sex with men to individual risk assessment: no evidence of a significant impact on the human immunodeficiency virus epidemic Italy","volume":"11","author":"Suligoi B","year":"2013","journal-title":"Blood Transf"},{"key":"e_1_2_6_7_1","unstructured":"Food and Drug Administration:Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products. Guidance for Industry December2015. Available onhttps:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/revised\u2010recommendations\u2010reducing\u2010risk\u2010human\u2010immunodeficiency\u2010virus\u2010transmission\u2010blood\u2010and\u2010blood[Last accessed 20 August 2019]"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14445"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12867"},{"key":"e_1_2_6_10_1","unstructured":"Ministerio de Salud Presidencia de la Naci\u00f3n:Resoluci\u00f3n 1507\/2015 y 1509\/205. Bolet\u00edn Oficial Rep\u00fablica Argentina N 33.217 Set de 2015. Resolution 1507\/2015 Available fromhttp:\/\/servicios.infoleg.gob.ar\/infolegInternet\/anexos\/250000\u2010254999\/252134\/norma.htmAccesssed on 18\/01\/2020 and Resolution 1509\/2015 from http:\/\/servicios.infoleg.gob.ar\/infolegInternet\/anexos\/250000\u2010254999\/252136\/norma.htm Accesssed on 18\/01\/2020."},{"key":"e_1_2_6_11_1","unstructured":"Ministerio de Salud Presidencia de la Naci\u00f3n:Resoluci\u00f3n 8618. Bolet\u00edn oficial A\u00f1o XCVIII Tomo DXLVII n8150 [cited Nov 2016] Argentina (27 de julio de 2010). Available fromhttp:\/\/boletinoficial.cba.gov.ar\/wp\u2010content\/4p96humuzp\/2014\/11\/110810_seccion1.pdf"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13946"},{"key":"e_1_2_6_13_1","unstructured":"Direcci\u00f3n de SIDA ETS Hepatitis y TBC Secretar\u00eda de Gobierno de Salud Ministerio de Salud y Desarrollo Social:Bolet\u00edn sobre VIH SIDA e ITS en la Argentina 2018;35 available onhttp:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000001385cnt\u20102018\u201012\u201020_boletin\u2010epidemiologico\u2010vih\u2010sida\u2010its_n35.pdf[Last accessed 20 August 2019]"},{"key":"e_1_2_6_14_1","unstructured":"Direcci\u00f3n de SIDA ETS Hepatitis y TBC Secretar\u00eda de Gobierno de Salud Ministerio de Salud y Desarrollo Social Argentina:Bolet\u00edn sobre VIH SIDA e ITS en la Argentina 2019;3 5 Available athttp:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000001754cnt\u2010boletin\u2010epidemiologico\u20102019_vih\u2010sida\u2010its.pdf[Last accessed 13 January 2020]"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvox.12933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.12933","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:47:25Z","timestamp":1693824445000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.12933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/vox.12933"],"URL":"https:\/\/doi.org\/10.1111\/vox.12933","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}